logo
logo

Mojia Biotech Completes Series B Financing To Advance Manufacturing Of Bio-Based Materials

Jun 23, 2022•about 3 years ago

Round Type

series b

Shanghai

Description

Mojia Biotech, a Shanghai-based leading bio-manufacturing company dedicated to sustainable development and carbon neutrality, announced the completion of an $80 million Series B Financing. The funds will be used to commercialize its ViridiminTM brand of animal-feed additives, scale up manufacturing capacity for AliphaneTM series of bio-based materials, advance its product pipeline and expand its global R&D capabilities.

Company Information

Company

Mojia Biotech

Location

Shanghai, Shanghai, China

About

Mojia Biotech is a fast-growing, product-focused bio-manufacturing company dedicated to the production of food ingredients and chemical materials using renewable carbon sources and green processes. It has R&D activities and partnerships across the world and manufacturing facilities in China. Learn more at www.mojiabio.com.